Lucid Capitalización de mercado
¿Qué es el Capitalización de mercado de Lucid?
El Capitalización de mercado de Lucid, Inc. es $3.66M
¿Cuál es la definición de Capitalización de mercado ?
La capitalización de mercado es el valor de mercado en un momento en el tiempo de las acciones en circulación de una empresa que cotiza en bolsa, que es igual al precio de la acción en ese punto de tiempo por el número de acciones en circulación .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Capitalización de mercado de compañías en Sector Health Care en OTC en comparadas con Lucid
¿Qué hace Lucid?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Empresas con capitalización de mercado similar a Lucid
- Jubilee Gold Exploration tiene Capitalización de mercado de $3.64M
- BCC Fuba India tiene Capitalización de mercado de $3.64M
- Pacific American tiene Capitalización de mercado de $3.65M
- Playfair Mining tiene Capitalización de mercado de $3.65M
- Universal Ibogaine tiene Capitalización de mercado de $3.65M
- Zenith Fibres tiene Capitalización de mercado de $3.66M
- Lucid tiene Capitalización de mercado de $3.66M
- Concord Drugs tiene Capitalización de mercado de $3.66M
- Canasil Resources tiene Capitalización de mercado de $3.66M
- Melkior Resources tiene Capitalización de mercado de $3.66M
- Media Lab S.p.A tiene Capitalización de mercado de $3.66M
- Jiulian Resources tiene Capitalización de mercado de $3.67M
- Metropolis Capital tiene Capitalización de mercado de $3.67M